GENE ONLINE|News &
Opinion
Blog

Merck
GeneOnline’s Weekly News Highlights: July 24-28
2023-08-01
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Merck, Eisai’s Keytruda-Lenvima Combo Fails in Melanoma and Colorectal Cancer Trials
2023-04-10
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Merck Expands Hematology Portfolio With $1.35 Billion Imago Buy
2022-11-22
Merck’s Streptococcus pneumoniae Expansion Finally Receives European Commission Approval
2022-10-24
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Merck Presents Positive News For Keytruda Combination in NSCLC
2022-09-13
AstraZeneca and Merck’s HER2-negative Breast Cancer Treatment Wins Yet Another Approval
2022-08-25
Merck’s Anticoagulant Therapy Scores Fast Track Designation From FDA
2022-08-23
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
1 2 3 6
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top